期刊文献+

皮肌炎患者外周血调节性T细胞/辅助性T细胞17的检测及意义 被引量:4

Expression and clinical significance of regulatory T cell and Th17 cell in the peripheral blood of pati-ents with dermatomyositis
原文传递
导出
摘要 目的探讨皮肌炎患者外周血调节性T细胞/辅助性T细胞17(Thl7)的变化及意义。方法选取36例皮肌炎患者和36名健康对照者,分别采用流式细胞术、实时定量逆转录聚合酶链反应和酶联免疫吸附法法检测外周血调节性T细胞frhl7细胞百分率、核转录因子叉头翼状螺旋转录因子3(Foxp3),视黄醇类核内受体.yt(RORrt)mRNA的表达以及血浆转化生长因子(TGF)-B,、白细胞介素(IL).17的水平。统计学处理采用t检验,相关分析采用Pearson直线相关分析。结果皮肌炎患者CD4+Foxp3+调节性T细胞百分率[(7.2±2.3)%]、Foxp3mRNA表达水平(0.44±0.19)以及血浆TGF-B,水平[(37400±4814)pg/ml]与健康对照组相比显著降低[(9.1±3.2)%、0.62±0.25、(41200~6348)pg/ml,P均〈0.05];与对照组相比,皮肌炎患者外周血中Thl7细胞百分率[(1.22±0.41)%]、ROR,/tmRNA表达水平(0.85~0.34)及血浆IL-17水平[(77~32)p咖1]显著高于对照组[(0.83±0.14)%、0.61i-0.21、(58+20)pg/m~](P均〈0.05)。CD4+Foxp3调节性T细胞百分率、Foxp3mRNA表达水平及血浆TGF.B,水平与血清肌酸激酶水平呈负相关(r==-0.573,-0.593,-0.618,P〈0.05),Thl7细胞百分率、RORr/tmRNA表达水平及血浆IL-17水平与肌酸激酶水平呈正相关(r=0.582,0.609,0.623,P〈0.05)。结论皮肌炎患者外周血中调节性T细胞frhl7细胞失衡可能与皮肌炎的发病有关。 [Abstract] Objective To explore the changes and clinical significance of regulatory T cell/T help cell 17 (Thl7) in the peripheral blood from patients with dermatomyositis (DM). Methods Thirty-six patients with DM were recruited and thirty-six healthy individuals were enrolled as normal controls. The percentage of regulatory T cell/Thl7 cell was assessed by flow cytometry and the mRNA levels of Foxp3/RORrt were detec- ted by real-time quantitative reverse transcription polymerase chain reaction (RT-PCR). The plasma levels of TGF-β1/IL-17 were measured by enzyme linked immunosorbent assay (ELISA). T-test was used for statistical analysis and Pearson's linear analysis were used for correlation analysis. Results The percentage of CD4+ Foxp3+ T cell, the mRNA expression of Foxp3 and the plasma levels of TGF-β1 decreased significantly in pati- ents with DM than in normal controls [ (7.2+2.3)% vs (9.1_+3.2)%, (0.44+0.19) vs (0.62+0.25), (37 400± 4814) pg/ml vs (41 200+6348) pg/ml, P〈O.05]. The percentage of Thl7 cell, the mRNA expression of RORrt and the plasma levels of IL-17 increased in patients with DM compared with normal controls [ ( 1.22± 0.41)% vs (0.83+0.14)%, (0.85+0.34)vs (0.61+0.21), (77±32)pg/ml vs (58+20)pg/ml, P〈0.05]. There was negative correlation between the percentage of regulatory T cell, the mRNA levels of Foxp3, the plasma levels of TGF-β1 and the serum levels of CK in patients with DM (r=--0.573, -0.593, -0.618, P〈0.05). There was positive correlation between the percentage of Thl7 cell, the mRNA levels of RORrt, the plasma levels of IL-17 and the serum levels of CK in patients with DM (r=0.582, 0.609, 0.623, P〈0.05). Conclusion The imbalance of regulatory T cell/Thl7 cell may exist in the peripheral blood of patients with DM. Regulatory T cellIThl7 cell may be associated with the pathology of DM.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2013年第2期127-129,共3页 Chinese Journal of Rheumatology
基金 基金项目:陕西省科技攻关计划(2008K09.09[11])
关键词 调节性T细胞 辅助性T细胞 皮肌炎 外周血 患者 实时定量逆转录聚合酶链反应 检测 MRNA表达 Dermatomyositis T-lymphocytes, helper-inducer Thl7 cell
  • 相关文献

参考文献10

  • 1Mammen AL. Dermatomyositis and polymyositis:clinical presentation,autoantibodies,and pathogenesis[J].Annals of the New York Academy of Sciences,2010.134-153.
  • 2韩磊,吕良敬.无肌病性皮肌炎的研究进展[J].中华风湿病学杂志,2011,15(11):795-797. 被引量:4
  • 3Piccirillo CA. Regulatory T cells in health and disease[J].Cytokine,2008.395-401.
  • 4Hori S,Nomura T,Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3[J].Science,2003.1057-1061.
  • 5Manel N,Unutmaz D,Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat[J].Nature Immunology,2008,(6):641-649.doi:10.1038/ni.1610.
  • 6Iannone F,Cauli A,Yanni G. T-lymphocyte immunophenotyping in polymyositis and dermatomyositis[J].British Journal of Rheumatology,1996.839-845.
  • 7吴蔚,王胜军,李遇梅,尤海燕,毛朝明,许化溪.活动性皮肌炎CD4^+CD25^+CD127^10/-调节性T细胞的检测[J].中华皮肤科杂志,2009,42(1):55-56. 被引量:1
  • 8Waschbisch A,Schwab N,Ruck T. FOXP3+ T regulatory cells in idiopathic inflammatory myopathies[J].Journal of Neuroimmunology,2010.137-142.
  • 9Kim GT,Cho ML,Park YE. Expression of TLR2,TLR4,and TLR9 in dermatomyositis and polymyositis[J].Clinical Rheumatology,2010.273-279.
  • 10Shen H,Xia L,Lu J. Interleukin-17 and interleukin-23 in patients with polymyositis and dermatomyositis[J].Scandinavian Journal of Rheumatology,2011.217-220.

二级参考文献33

  • 1刘越阳,何春涤,徐宏慧,王雅坤,陈洪铎.皮肌炎与四种人类疱疹病毒相关性的研究[J].中华皮肤科杂志,2005,38(1):50-51. 被引量:5
  • 2叶霜,黄文群,吴美芳,邓筠,陈晓翔,杨程德,郭强,顾越英,鲍春德,陈顺乐.以急进性肺间质病变为突出表现的无肌炎的皮肌炎[J].中华风湿病学杂志,2006,10(9):527-533. 被引量:30
  • 3曹华,郑捷.皮肌炎样皮炎还是无肌病性皮肌炎?——关于无肌病性皮肌炎命名的商榷[J].中国皮肤性病学杂志,2006,20(10):630-632. 被引量:3
  • 4Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4^+ T reg cells. J Exp Med, 2006, 203(7): 1701-1711.
  • 5Bohan A, Peter JB. Polymyositis and dermatornyositis. N Engl J Med, 1975, 292(8): 403-405.
  • 6Grundtman C, Malmstrom V, Lundberg IE, et al. Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies. Arthritis Res Ther, 2007, 9(2): 208-220.
  • 7Sontheimer RD. Cutaneous features of classical dermatomyositis and amyopathic dermatomyositis.Curr Opin Rheumatol, 1999, 11 : 475-482.
  • 8Euwer R, Sontheimer RD. Amyopathic dermatomyositis:a review. J Invest Dermatol, 1993, 100: 1245-1275.
  • 9Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomy- opathies spectrum of clinical illness. J Am Acad Dermatol, 2002, 46: 626-636.
  • 10Sato S, Hoshino K, Satoh T, et al. RNA helicase encoded by melanoma diff, gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: associa- tion with rapidly progressive interstitial lung disease. Arthritis Rheum, 2009, 60: 2193-2200.

共引文献3

同被引文献40

  • 1王炎焱,黄烽,张莉芸.沙利度胺治疗风湿性疾病的研究进展[J].中华风湿病学杂志,2004,8(12):758-760. 被引量:16
  • 2周玮,张育.沙利度胺的作用机制及抗类风湿关节炎作用研究进展[J].医药导报,2007,26(4):399-402. 被引量:17
  • 3Reed AM, Emste F. The inflammatory milieu in idiopathic inflammatory myositis. Curr Rheumatol Rep, 2009,11 (4) :295 -301.
  • 4Banica L, Besliu A, Pistol G, et al. Quantification and molecular char- acterization of regulatory T cells in connective tissue diseases[ J ]. Auto- immunity, 2009,42( 1 ) :41 -49.
  • 5Sanner H, Gran JT, Sjaastad I, et ah Cumulative organ damage and prognostic factors in juvenile dermatomyositis : a cross - sectional study median 16.8 years after symptom onset[ J]. Rheumatology( Oxford), 2009,48 (12) : 1541 - 1547.
  • 6Piccirillo CA. Regulatory T cells in health and disease[ J]. Cytokine, 2008,43 ( 3 ) :395 - 401.
  • 7Manel N, Unntmaz D, Littman DR. The differentiation of human T(H) - 17 cells requires transforming growth factor - beta and induction of the nuclear receptor ROR gammat [ J 1. Nat Immunol, 2008,9 ( 6 ) : 641 - 649.
  • 8Ishii W, Matsuda M, Shimojima Y, et al. Flow cutomeric analysis of lymphocyte subpopulations and Thl/Th2 balance in patients with poly- myositis and dermatomyositis [ J ]. Inter Med, 2008,47 ( 18 ) : 1593 - 1599.
  • 9Alelaza M, Szegedi A, Antal - Szalmas P, et al. Altered cytokine ex- pression of peripheral blood lymphocytes in polymyosits and dematomysi- tis[J]. Ann Rheum Dis, 2005,64(10) :1485 - 1489.
  • 10中国多发性骨髓瘤诊治指南[J].中华内科杂志,2008,47(10):869-872. 被引量:87

引证文献4

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部